top of page
NJPN_Conference-2021_BG-4.jpg
NJPN_Conference_Logo_Color-RGB.png
ON-DEMAND THRU DEC 2021 • ONLINE EVERYWHERE
Christopher M. Jones
Texture-7-G@2x.png
Blooms-1.png

Christopher M. Jones

Deputy Director, National Center for Injury Prevention and Control

Centers for Disease Control and Prevention (CDC)

As Deputy Director of the CDC Injury Center, Dr. Christopher Jones drives the Center’s strategic direction by overseeing the refinement of the scientific research agenda and the coordination of center priorities. He oversees and enhances collaboration among the Offices of Science, Informatics, Strategy and Innovation, and Opioid Response Coordinating Unit.


Previously, Dr. Jones served as Senior Advisor to the Injury Center and provided strategic policy and scientific direction and coordination on a broad range of injury and violence topics including drug overdose, suicide, and adverse childhood experiences. Additionally, as Associate Director, he led strategic planning efforts and the development of Injury Center programs and topics; led scientists and public health practitioners to advance innovative approaches to using data to inform prevention efforts, built partnerships to advance public health data and surveillance, and strengthened interagency and nongovernmental collaborations on injury and violence prevention. He also served as a senior scientist conducting epidemiological and policy research. Prior to joining CDC, he served as the first Director of the National Mental Health and Substance Use Policy Laboratory at SAMHSA. 


Dr. Jones received his Bachelor of Science degree from Reinhardt College, his Doctor of Pharmacy degree from Mercer University, his Master of Public Health degree from New York Medical College, and his Doctorate of Public Health degree in health policy from The George Washington University Milken Institute School of Public Health.

Presentation information is being cultivated. Please check back soon.

DAY 1 AM WORKSHOP

Substance Use & Adverse Childhood Experiences — Opportunities for Prevention

Adverse Childhood Experiences (ACEs) are potentially traumatic events that occur in childhood, such as experiencing violence, abuse, or neglect; witnessing violence in the home; and having a family member attempt or die by suicide. Aspects of a child’s environment can undermine their sense of safety, stability, and bonding, such as growing up in a household with substance misuse, mental health problems, or instability due to parental separation or incarceration of a parent or caregiver. Data show that approximately two-thirds of adults in the U.S. report having experienced at least one ACE and 1 in 6 adults have reported 4 or more ACEs before the age of 18. More than two decades of research has documented the effects of ACEs on health, wellbeing, and opportunity across the lifespan. A longstanding and robust body of research links ACEs to increased risk for substance use and substance use disorders (SUDs). More recent research confirms that ACEs are a strong risk factor specifically for both opioid and methamphetamine and other stimulant use. Thus, preventing ACEs is a potentially potent strategy to reduce substance use and its related harms. The proposed presentation will explore this empirical relationship between ACEs and substance use and SUD, with particular focus on CDC’s approach to addressing the intersection of risk and prevention for both ACEs and substance use. The presentation will also describe CDC’s ACEs prevention resource – Preventing Adverse Childhood Experiences: Leveraging the Best Available Evidence – that offers multiple strategies to support comprehensive policies, programs, and practices that can be implemented to prevent ACEs and mitigate their harms.

RENEWAL/CEU CREDIT

This workshop is approved for 1-hour Renewal Credit/CEU for: IC&RC/NJ-AP Certification Board | NAADAC | DOE | NASW-NJ [General Credit]

Lines-G.png
2021-Conference-BG-2-80.jpg
NJPN_Conference_Logo_Color-RGB.png
A Virtual Conference for All Professionals
Supporting Those Impacted by Addiction
APRIL 29 & 30 • ON-DEMAND THRU DEC 2021
bottom of page